Welcome Message

Dear Esteemed Colleagues and Participants,

It is with great pleasure that we welcome you to the 12th World Summit on Epilepsy and Bipolar Disorders, scheduled for August 07-08, 2025, in the enchanting city of Paris, France. This prestigious event, titled Epilepsy Summit 2025, brings together the leading minds in neurology, psychiatry, and related disciplines to explore the latest advancements, research, and treatment strategies in the fields of epilepsy and bipolar disorders. Over the course of two days, we will engage in thought-provoking discussions, share cutting-edge research, and collaborate on innovative approaches to improve patient care and outcomes.

Paris, a city renowned for its rich history, cultural heritage, and academic excellence, provides the perfect backdrop for this summit. As we gather in this iconic location, we encourage you to take advantage of the opportunity to network with fellow experts, exchange ideas, and forge new collaborations that will shape the future of epilepsy and bipolar disorder treatment. We look forward to your active participation and are confident that Epilepsy Summit 2025 will be an enriching and inspiring experience for all.

Thanks & Regards
Organizing Committee

About the Conference

The 12th World Summit on Epilepsy and Bipolar Disorders, known as Epilepsy Summit 2025, is a premier international conference dedicated to advancing the understanding, diagnosis, and treatment of epilepsy and bipolar disorders. Scheduled for August 07-08, 2025, in Paris, France, this summit will feature a diverse array of sessions, including keynote addresses, panel discussions, and workshops led by some of the foremost experts in the field.

The conference aims to address the latest research findings, emerging therapies, and best practices in managing these complex conditions. Attendees will have the opportunity to engage in in-depth discussions on cutting-edge topics, including novel treatment modalities, neurobiological mechanisms, and patient-centered approaches. By fostering collaboration and knowledge exchange, Epilepsy Summit 2025 seeks to drive forward progress in clinical and research domains, ultimately enhancing the quality of care for individuals affected by epilepsy and bipolar disorders.

Scientific Sessions &Tracks

Advances in Epilepsy Research and Treatment

Recent advancements in epilepsy research have led to significant breakthroughs in understanding the underlying mechanisms of seizures and epilepsy. New studies are exploring the molecular and genetic factors that contribute to the development and progression of epilepsy. Additionally, advancements in neurotechnology and data analytics are enhancing our ability to monitor and treat epilepsy with greater precision. These innovations promise to improve patient outcomes by providing more targeted and personalized treatment options.

Emerging therapies, such as novel antiepileptic drugs and neuromodulation techniques, are revolutionizing the management of epilepsy. Researchers are investigating the efficacy of these treatments in various patient populations, including those with drug-resistant epilepsy. The integration of these advancements into clinical practice holds the potential to transform the landscape of epilepsy treatment, offering hope for better control and quality of life for individuals living with this condition.

Novel Biomarkers in Epilepsy Diagnosis

The search for reliable biomarkers in epilepsy diagnosis is a rapidly evolving field, with researchers identifying potential indicators that could enhance diagnostic accuracy and treatment efficacy. Biomarkers such as specific proteins, genetic mutations, and neuroimaging features are being studied for their ability to differentiate between various types of epilepsy and predict treatment responses. These biomarkers could lead to earlier and more precise diagnosis, allowing for timely intervention and personalized treatment plans.

In addition to diagnostic applications, novel biomarkers are being explored for their role in monitoring disease progression and treatment outcomes. Advances in high-throughput technologies and bioinformatics are facilitating the identification and validation of these biomarkers. As research continues, these findings could lead to the development of new diagnostic tools and therapeutic strategies, ultimately improving the management of epilepsy and enhancing patient care.

Neuroimaging Techniques in Epilepsy

Neuroimaging techniques have become crucial in the diagnosis and management of epilepsy, providing valuable insights into brain structure and function. Advanced imaging modalities, such as functional MRI (fMRI), magnetoencephalography (MEG), and positron emission tomography (PET), are being utilized to localize epileptic foci, assess brain connectivity, and evaluate the impact of seizures on cognitive function. These techniques enable clinicians to better understand the neural basis of epilepsy and tailor treatment approaches accordingly.

The integration of neuroimaging with other diagnostic tools, such as electroencephalography (EEG) and genetic testing, is enhancing the accuracy and specificity of epilepsy diagnosis. Researchers are also exploring the potential of neuroimaging for predicting treatment responses and monitoring disease progression. As imaging technologies continue to advance, they hold promise for improving the precision and effectiveness of epilepsy management, ultimately benefiting patients through more individualized and targeted interventions.

Drug-Resistant Epilepsy: Current Challenges and Solutions

Drug-resistant epilepsy remains a significant challenge in the field, with a substantial proportion of patients not achieving adequate seizure control with available antiepileptic medications. This session will explore the underlying factors contributing to drug resistance, including genetic, pharmacokinetic, and pharmacodynamic considerations. Understanding these mechanisms is crucial for developing new therapeutic strategies and optimizing treatment regimens for drug-resistant epilepsy.

Recent research is focused on identifying novel drug targets and developing innovative treatment approaches, such as personalized medicine and drug delivery systems. Advances in genetic and molecular research are providing insights into potential therapeutic targets and mechanisms of drug resistance. By addressing these challenges and exploring new solutions, the goal is to improve seizure control and quality of life for individuals with drug-resistant epilepsy.

The Role of Genetics in Epilepsy

Genetics plays a pivotal role in the development and progression of epilepsy, with numerous genetic mutations and variations implicated in various forms of the disorder. This session will review recent discoveries in epilepsy genetics, including the identification of genes associated with specific epilepsy syndromes and the impact of genetic testing on diagnosis and treatment. Understanding the genetic basis of epilepsy can lead to more precise diagnoses and targeted therapies.

The integration of genetic information into clinical practice is advancing the field of personalized medicine in epilepsy. Genetic testing can provide insights into an individual’s risk of developing epilepsy, guide treatment decisions, and inform prognosis. Ongoing research aims to uncover new genetic markers and understand their role in epilepsy pathogenesis, with the potential to revolutionize how epilepsy is diagnosed and managed.

Epilepsy Surgery: Latest Innovations and Techniques

Epilepsy surgery has emerged as a crucial option for patients with drug-resistant epilepsy, offering the potential for seizure freedom and improved quality of life. This session will highlight the latest innovations in surgical techniques, including advancements in image-guided surgery, minimally invasive procedures, and intraoperative monitoring. These innovations aim to enhance the precision and effectiveness of epilepsy surgery, reducing risks and improving outcomes.

The development of new surgical approaches and technologies is enabling more tailored and individualized treatment options for epilepsy patients. Research into patient selection criteria and preoperative evaluation techniques is also evolving, ensuring that surgical interventions are optimized for each patient’s unique condition. By incorporating these advancements, the goal is to provide more effective and safer surgical options for individuals with epilepsy.

Cognitive and Behavioral Effects of Epilepsy

Epilepsy can have significant cognitive and behavioral effects, impacting various aspects of daily life and overall functioning. This session will explore the cognitive impairments and behavioral changes associated with epilepsy, including issues related to memory, attention, and executive function. Understanding these effects is essential for developing comprehensive treatment plans that address both the neurological and psychological aspects of the disorder.

Research is also focusing on the impact of epilepsy on quality of life and psychosocial well-being. Interventions aimed at improving cognitive function and managing behavioral symptoms are being investigated, including cognitive rehabilitation therapies and psychological support. By addressing these aspects of epilepsy, the goal is to enhance overall patient well-being and provide a more holistic approach to epilepsy management.

Epilepsy in Pediatrics: Management and Outcomes

Epilepsy in pediatric populations presents unique challenges and considerations, including the impact on development, learning, and social interactions. This session will examine the specific management strategies and treatment options for children with epilepsy, highlighting the importance of early intervention and tailored approaches. Addressing the needs of pediatric patients requires a multidisciplinary approach that involves neurologists, developmental specialists, and educators.

Long-term outcomes and the impact of epilepsy on developmental trajectories are also critical areas of focus. Research into the effectiveness of various treatments and their effects on cognitive and behavioral development is ongoing. By understanding and addressing these factors, the aim is to improve long-term outcomes and quality of life for children with epilepsy and their families.

Advances in Anti-Seizure Medications

The development of new anti-seizure medications (ASMs) is crucial for improving seizure control and minimizing side effects in individuals with epilepsy. This session will review the latest advancements in ASM research, including the introduction of novel drugs, new formulations, and updated treatment guidelines. Advances in pharmacology and drug delivery systems are enhancing the effectiveness and tolerability of epilepsy treatments.

Research is also focusing on personalized medicine approaches, aiming to tailor ASM therapies to individual patient needs based on genetic and clinical factors. The goal is to provide more effective and individualized treatment options that optimize seizure control while minimizing adverse effects. By staying abreast of these advancements, clinicians can better manage epilepsy and improve patient outcomes.

Exploring Epilepsy and Mental Health Comorbidities

Epilepsy is often associated with various mental health comorbidities, including depression, anxiety, and psychosis. This session will explore the complex interplay between epilepsy and mental health, examining how seizures and epilepsy-related factors contribute to these conditions. Understanding these relationships is essential for developing comprehensive treatment plans that address both neurological and psychological aspects.

Research into the management of comorbid mental health conditions in epilepsy patients is ongoing, with a focus on integrated treatment approaches that combine pharmacological and psychological interventions. Addressing mental health comorbidities is crucial for improving overall quality of life and treatment outcomes for individuals with epilepsy. By addressing these issues holistically, clinicians can provide more effective and supportive care.

Bipolar Disorder: Current Understanding and Future Directions

Bipolar disorder is a complex mood disorder characterized by extreme mood swings, including manic and depressive episodes. This session will review the current understanding of bipolar disorder, including its etiology, neurobiological mechanisms, and clinical features. Recent research advancements are providing new insights into the pathophysiology of bipolar disorder and informing future directions for treatment and management.

Future directions in bipolar disorder research include exploring novel therapeutic approaches, improving diagnostic criteria, and enhancing our understanding of the disorder’s genetic and environmental factors. Advances in psychopharmacology, psychotherapy, and psychosocial interventions are shaping the future of bipolar disorder treatment, with the goal of providing more effective and individualized care for individuals living with the condition.

Pharmacological Treatments for Bipolar Disorder

Pharmacological treatments for bipolar disorder aim to stabilize mood and manage symptoms effectively. This session will focus on the latest developments in medication options, including mood stabilizers, antipsychotics, and adjunctive therapies. Recent research is exploring the efficacy and safety of new drug formulations, as well as strategies for optimizing treatment regimens to address individual patient needs.

The session will also address challenges associated with pharmacological treatment, such as managing side effects, ensuring medication adherence, and tailoring treatment plans based on patient-specific factors. Advances in drug development and personalized medicine are contributing to more effective and targeted treatment approaches for bipolar disorder. By staying informed about these advancements, clinicians can better manage the disorder and improve patient outcomes.

Psychosocial Interventions in Bipolar Disorder

Psychosocial interventions play a crucial role in the comprehensive management of bipolar disorder, complementing pharmacological treatments. This session will review various psychosocial approaches, including cognitive-behavioral therapy (CBT), psychoeducation, and family therapy. These interventions aim to address the psychological and social aspects of bipolar disorder, improve coping skills, and enhance overall functioning.

Research into the effectiveness of psychosocial interventions is ongoing, with a focus on developing evidence-based practices and integrating these approaches into standard care. The goal is to provide patients with tools and support to manage their condition more effectively and improve their quality of life. By incorporating psychosocial interventions into treatment plans, clinicians can offer a more holistic and supportive approach to managing bipolar disorder.

The Impact of Bipolar Disorder on Quality of Life

Bipolar disorder can significantly impact an individual’s quality of life, affecting various domains such as work, relationships, and daily functioning. This session will explore the ways in which bipolar disorder influences quality of life, including the effects of mood episodes, medication side effects, and comorbid conditions. Understanding these impacts is essential for developing strategies to improve overall well-being.

Research into quality of life outcomes for individuals with bipolar disorder is helping to identify key areas for intervention and support. By addressing factors that affect quality of life, such as social support, employment, and self-care, clinicians can work to enhance the overall functioning and satisfaction of individuals living with bipolar disorder. The aim is to improve life quality through comprehensive and personalized care strategies.

Genetic and Epigenetic Factors in Bipolar Disorder

Genetic and epigenetic factors play a significant role in the development and progression of bipolar disorder. This session will review recent research into the genetic and epigenetic underpinnings of the disorder, including the identification of susceptibility genes and the role of environmental influences. Understanding these factors can provide insights into the etiology of bipolar disorder and inform new approaches to treatment.

Advances in genomic and epigenomic research are uncovering the complex interactions between genetic predisposition and environmental factors. This knowledge has the potential to lead to the development of personalized treatment strategies and targeted interventions. By exploring these factors, researchers aim to enhance our understanding of bipolar disorder and improve treatment outcomes through precision medicine approaches.

Bipolar Disorder and Suicidality: Risk Assessment and Management

Suicidality is a critical concern in bipolar disorder, with individuals at increased risk of self-harm during mood episodes. This session will focus on risk assessment and management strategies for addressing suicidality in bipolar disorder. Topics will include the identification of risk factors, the use of screening tools, and the implementation of safety plans and crisis interventions.

Research into effective management strategies for suicidality in bipolar disorder is ongoing, with a focus on improving risk assessment, prevention, and treatment. By understanding and addressing the factors contributing to suicidality, clinicians can provide more effective support and intervention for individuals at risk. The goal is to reduce suicide risk and enhance overall safety and well-being for patients with bipolar disorder.

Advances in Mood Stabilizers for Bipolar Disorder

Mood stabilizers are a cornerstone of bipolar disorder treatment, aiming to manage mood swings and prevent relapses. This session will review the latest advancements in mood stabilizer medications, including new drug formulations, combination therapies, and emerging treatments. Research into the efficacy, safety, and tolerability of these medications is crucial for optimizing treatment outcomes.

The session will also address challenges related to mood stabilizer therapy, such as managing side effects, ensuring medication adherence, and tailoring treatment to individual patient needs. Advances in pharmacological research and personalized medicine are contributing to the development of more effective and individualized mood stabilizer treatments. The goal is to enhance treatment effectiveness and improve patient outcomes.

Bipolar Disorder: New Diagnostic Criteria and Tools

Accurate diagnosis of bipolar disorder is essential for effective treatment and management. This session will explore recent updates to diagnostic criteria and tools for bipolar disorder, including revisions to diagnostic manuals, the development of new assessment instruments, and advancements in clinical evaluation. Understanding these changes is important for improving diagnostic accuracy and treatment planning.

The session will also discuss the impact of these updates on clinical practice, including the implications for diagnosis, treatment, and patient care. Advances in diagnostic tools and criteria aim to enhance the precision and consistency of bipolar disorder diagnoses, ultimately leading to better treatment outcomes. By staying informed about these developments, clinicians can ensure they are using the most current and effective diagnostic approaches.

Neuroimaging in Bipolar Disorder Research

Neuroimaging techniques have become a valuable tool in bipolar disorder research, providing insights into brain structure and function related to mood regulation. This session will review recent advancements in neuroimaging research, including studies using MRI, PET, and fMRI to investigate neural correlates of bipolar disorder. These techniques offer valuable information on brain abnormalities and functional changes associated with the disorder.

The integration of neuroimaging findings with clinical data is enhancing our understanding of bipolar disorder and informing new treatment approaches. Research is also exploring the potential of neuroimaging for predicting treatment responses and monitoring disease progression. By leveraging these advancements, researchers and clinicians aim to improve diagnostic accuracy and develop more targeted and effective treatments for bipolar disorder.

Integrative Approaches in Managing Epilepsy and Bipolar Disorder

Integrative approaches to managing epilepsy and bipolar disorder involve combining various treatment modalities to address both neurological and psychological aspects of these conditions. This session will explore the benefits of integrating pharmacological treatments, psychotherapy, lifestyle interventions, and complementary therapies in the management of epilepsy and bipolar disorder.

Research into integrative approaches is highlighting the potential for improved outcomes by addressing the complex interplay between these disorders and their treatments. By incorporating multiple strategies into care plans, clinicians can offer a more comprehensive and holistic approach to managing both epilepsy and bipolar disorder. The goal is to enhance overall treatment effectiveness and patient quality of life through a multifaceted and individualized approach.

Market Analysis

The global market for epilepsy and bipolar disorder treatments is experiencing significant growth driven by increasing prevalence rates, advancements in medical research, and a rising demand for innovative therapies. As of 2024, the epilepsy treatment market is valued at approximately $6.5 billion and is projected to grow at a compound annual growth rate (CAGR) of around 6% over the next five years. This growth is fueled by the ongoing development of novel antiepileptic drugs (AEDs), improved diagnostic tools, and expanded access to specialized care. Similarly, the bipolar disorder treatment market, currently valued at around $5 billion, is expected to see a CAGR of 5.5% due to increased awareness, better treatment options, and ongoing research into effective management strategies.

The Epilepsy Summit 2025 is strategically positioned to address key trends and challenges within this evolving market. With an emphasis on cutting-edge research and emerging treatment modalities, the summit offers a unique opportunity for stakeholders to explore the latest advancements and network with leading experts. The conference will highlight innovative therapies, such as personalized medicine and neuromodulation techniques, which are gaining traction in both markets. Additionally, the summit will address the growing need for multidisciplinary approaches and patient-centered care, reflecting the broader shift towards integrated and holistic treatment models. By convening a diverse group of professionals and researchers, Epilepsy Summit 2025 aims to drive forward progress in these critical areas, ultimately contributing to improved patient outcomes and market growth.

Why Attend Epilepsy Summit 2025?

• Cutting-Edge Research: Gain insights into the latest research and advancements in the fields of epilepsy and bipolar disorders from leading experts.
• Innovative Treatments: Explore emerging therapies and novel treatment strategies that are shaping the future of patient care.
• Expert Networking: Connect with a diverse group of professionals, researchers, and clinicians to foster collaborations and share knowledge.
• In-Depth Workshops: Participate in interactive workshops and panel discussions that offer practical solutions and hands-on experience in managing these conditions.
• Global Perspectives: Learn about different approaches and perspectives from an international community of specialists, enhancing your understanding of global practices and challenges.
• Professional Development: Enhance your skills and knowledge with up-to-date information, contributing to your professional growth and expertise in the field.
• Scenic Venue: Experience the historic and cultural richness of Paris, providing a unique and inspiring setting for the summit.

Abstract Submission Criteria & Eligibility

Eligibility:

• Academic and Clinical Professionals: Abstracts are invited from researchers, clinicians, and academics working in the fields of epilepsy, bipolar disorders, neurology, psychiatry, and related disciplines.
• Students and Early Career Researchers: Submissions from students and early career researchers are welcome, provided they meet the thematic relevance and quality criteria.
• Multi-Disciplinary Contributions: Submissions from professionals in related fields (e.g., pharmacology, neuroimaging, psychology) that offer relevant insights into epilepsy and bipolar disorders are encouraged.

Abstract Submission Criteria:

• Originality: Abstracts must present original research, reviews, or case studies that have not been published or presented at other major conferences before the summit.
• Relevance: The abstract should align with the themes of the conference, focusing on advancements in research, treatment strategies, or clinical practices related to epilepsy and bipolar disorders.
• Format: Abstracts should be submitted in a structured format, including a clear title, objectives, methods, results, and conclusions. Adherence to specific word limits and formatting guidelines (e.g., font size, spacing) provided by the conference is required.
• Clarity and Quality: Abstracts should be written in clear, concise language, and demonstrate methodological rigor and scientific merit.
• Co-Authors: Include all contributing authors and their affiliations. Ensure that all authors have agreed to the submission and are aware of their roles and responsibilities.
• Submission Deadlines: Abstracts must be submitted by the specified deadline, with any extensions or late submissions considered on a case-by-case basis.

Review and Acceptance:

• Peer Review: Submitted abstracts will undergo a peer-review process to assess scientific quality, relevance, and clarity.
• Notification: Authors will be notified of acceptance or rejection based on the review process, and feedback may be provided to enhance the quality of the presentation.
•  

Participation/Presentation Options

Oral Presentation:

• Format: Deliver a 15-20 minute presentation followed by a Q&A session.
• Content: Present original research findings, significant case studies, or novel treatment strategies.
• Preparation: Prepare a detailed presentation with visual aids (e.g., slides) to effectively communicate your findings to a live audience.

Poster Presentation:

• Format: Display a visual poster summarizing your research or clinical work. Engage with attendees during dedicated poster sessions.
• Content: Provide a clear and concise overview of your study, including objectives, methods, results, and conclusions.
• Preparation: Create an informative and visually appealing poster, adhering to the conference’s size and formatting guidelines.

Workshop Facilitation:

• Format: Lead an interactive workshop or breakout session focused on specific techniques, methodologies, or practical applications related to epilepsy and bipolar disorders.
• Content: Design a session that encourages participant engagement, skill development, and hands-on learning.
• Preparation: Develop a structured workshop agenda, including materials and activities that facilitate active participation and knowledge exchange.

Panel Discussion:

• Format: Participate as a panelist in a discussion on a particular topic or issue related to epilepsy and bipolar disorders.
• Content: Share your expertise and contribute to a group discussion, providing insights and perspectives on current challenges and solutions.
• Preparation: Collaborate with other panelists and prepare key points and responses to potential questions or discussion topics.

Symposium Contribution:

• Format: Contribute to a symposium or thematic session organized around a specific topic of interest within the fields of epilepsy and bipolar disorders.
• Content: Present a talk or participate in a discussion within the context of the symposium’s theme.
• Preparation: Coordinate with symposium organizers to ensure your contribution aligns with the session’s objectives and format.

Each presentation option offers a unique platform for sharing your research and expertise, contributing to the overall success of Epilepsy Summit 2025.